Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Evogene (EVGN) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Evogene (EVGN) over the last 14 years, with Q3 2025 value amounting to 873.08%.

  • Evogene's EBIT Margin fell 5328500.0% to 873.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 275.91%, marking a year-over-year increase of 370800.0%. This contributed to the annual value of 337.17% for FY2024, which is 1328300.0% up from last year.
  • According to the latest figures from Q3 2025, Evogene's EBIT Margin is 873.08%, which was down 5328500.0% from 347.4% recorded in Q2 2025.
  • Evogene's EBIT Margin's 5-year high stood at 97.52% during Q1 2024, with a 5-year trough of 5666.23% in Q3 2021.
  • In the last 5 years, Evogene's EBIT Margin had a median value of 1060.22% in 2023 and averaged 1604.84%.
  • Data for Evogene's EBIT Margin shows a peak YoY increase of 72644200bps (in 2021) and a maximum YoY decrease of -39089500bps (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Evogene's EBIT Margin stood at 2794.86% in 2021, then soared by 79bps to 573.03% in 2022, then tumbled by -130bps to 1319.72% in 2023, then surged by 79bps to 283.49% in 2024, then plummeted by -208bps to 873.08% in 2025.
  • Its last three reported values are 873.08% in Q3 2025, 347.4% for Q2 2025, and 168.82% during Q1 2025.